Hyaluronate and Derivatives and Tisagenlecleucel Intravenous
Determining the interaction of Hyaluronate and Derivatives and Tisagenlecleucel Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronan
Brand name: Hymovis, Monovisc, Orthovisc, Hydase
Synonyms: Hyaluronan
Generic Name: tisagenlecleucel
Brand name: Kymriah
Synonyms: Tisagenlecleucel
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronate and Derivatives-Titralac
- Hyaluronate and Derivatives-Tivicay
- Hyaluronate and Derivatives-Tivicay (Dolutegravir 10 mg)
- Hyaluronate and Derivatives-Tivicay (Dolutegravir 25 mg and 50 mg)
- Hyaluronate and Derivatives-Tivorbex
- Hyaluronate and Derivatives-Tizanidine
- Tisagenlecleucel Intravenous-Hyaluronate and Derivatives Injection (Knee)
- Tisagenlecleucel Intravenous-Hyaluronate sodium Injection
- Tisagenlecleucel Intravenous-Hyaluronidase
- Tisagenlecleucel Intravenous-Hyaluronidase and immune globulin
- Tisagenlecleucel Intravenous-Hyaluronidase and rituximab
- Tisagenlecleucel Intravenous-Hyaluronidase and trastuzumab